SeLux Diagnostics

Selux Diagnostics is a healthcare startup that operates in the field of antibiotic susceptibility testing (AST). The company's mission is to combat antimicrobial resistance (AMR), a global health crisis that is seeing bacteria evolve faster than science, leading to resistance to lifesaving antibiotics. Selux aims to preserve the effectiveness of antibiotics for future generations by providing faster diagnostic results, comprehensive susceptibility testing, and updated breakpoints.

The company's primary clients are hospitals and healthcare providers who need accurate and rapid AST to prescribe the correct antibiotics. Selux's technology allows testing against all commercially relevant antibiotics at once, which is a significant innovation in a field that hasn't seen substantial progress in over two decades.

Selux's business model revolves around providing its AST technology to healthcare providers. The company makes money by selling its testing services, which are crucial in the fight against antibiotic resistance. By providing faster and more accurate results, Selux helps reduce the unnecessary or incorrect prescription of antibiotics, which is a significant issue in hospitals.

In summary, Selux Diagnostics is a pioneering healthcare startup that is addressing the global health crisis of antibiotic resistance through its innovative AST technology. The company serves healthcare providers by offering rapid and comprehensive antibiotic susceptibility testing, helping to ensure the correct prescription of antibiotics and ultimately saving lives.

Keywords: Healthcare, Antibiotic Susceptibility Testing, Antimicrobial Resistance, Diagnostics, Innovation, Antibiotics, Hospitals, Breakpoints, Rapid Testing, Lifesaving.